Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cecal Neoplasms”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Large-scale testing (Phase 3)Study completedNCT00052962
What this trial is testing

Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis

Who this might be right for
Gastrointestinal Neoplasm
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT03949777
What this trial is testing

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

Who this might be right for
Colonic PolypColonic NeoplasmsColonic Diseases+4 more
GI View Ltd. 79
Not applicableUnknownNCT03355495
What this trial is testing

R vs L Lateral Decubitus Positioning in Colonoscopy

Who this might be right for
Colonic AdenomaColonic Cancer
Memorial University of Newfoundland 172
Not applicableStudy completedNCT03254498
What this trial is testing

Detection in Tandem Endocuff Cap Trial

Who this might be right for
Colonic NeoplasmsAdenomas SerratedColo-rectal Cancer+1 more
London North West Healthcare NHS Trust 154
Not applicableUnknownNCT03776435
What this trial is testing

CT Carcinogenic Risk in Patients With Appendicitis

Who this might be right for
Computed TomographyCarcinogenesisRadiation Exposure+1 more
Seoul National University Bundang Hospital 1,000,000
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Early research (Phase 1)Looking for participantsNCT07487168
What this trial is testing

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Who this might be right for
Peritoneal Carcinomatosis
H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableStudy completedNCT06943924
What this trial is testing

A Comparative Study of CCI, EmSFI, and FTRST Scoring Systems

Who this might be right for
One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical InterventionsClinical Utility of These Scoring SystemsGastrointestinal Neoplasms+2 more
Dr. Lutfi Kirdar Kartal Training and Research Hospital 100
Early research (Phase 1)Study completedNCT00019773
What this trial is testing

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Who this might be right for
Carcinoma of the AppendixColorectal CancerSmall Intestine Cancer
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07769346
What this trial is testing

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

Who this might be right for
Appendix CancerPseudomyxoma Peritonei
Appendix Cancer Pseudomyxoma Peritonei Research Foundation 10,000
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Not applicableStudy completedNCT02374411
What this trial is testing

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Who this might be right for
Pseudomyxoma PeritoneiAppendiceal NeoplasmsPancreatic Neoplasms+4 more
Edward Hospital 55
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT01815359
What this trial is testing

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Who this might be right for
Appendix CancerColorectal Cancer
Memorial Sloan Kettering Cancer Center 292
Testing effectiveness (Phase 2)Study completedNCT02963831
What this trial is testing

Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Who this might be right for
Colorectal CancerOvarian CancerAppendiceal Cancer
Ludwig Institute for Cancer Research 67
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Not applicableStudy completedNCT04526886
What this trial is testing

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Who this might be right for
Colorectal CancerGastric CancerEsophageal Cancer+3 more
Dartmouth-Hitchcock Medical Center 52
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Not applicableActive Not RecruitingNCT01946854
What this trial is testing

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

Who this might be right for
Gastrointestinal Neoplasms
M.D. Anderson Cancer Center 30
Next Page